Research

Research published in the American Journal of Health Promotion shows evidence that health coaching can support healthy changes in lifestyle, reduce health risks and increase Healthy Days. Healthy Days is the U.S. Centers for Disease Control and Prevention assessment tool that Humana uses to track the mentally and physically Unhealthy Days of their members over a 30-day period.

To better understand how to support the health of our members, Humana sponsored a study which found significant reductions in average total Unhealthy Days across all goal categories.

Healthy Days is a reliable, validated assessment tool, designed to measure perceived health-related quality of life. Healthy Days provides a holistic view of health and well-being that reflects both  physical and mental domains and can appropriately capture the complex and subjective experience of individuals in health coaching programs.

As Humana explores ways to help members achieve their best health, health coaching and navigation is one way they are seeing success in reducing hospital admissions and improving medication adherence.   

Humana’s Bold Goal, a business and population health strategy to help improve the health of the communities the company serves 20 percent by 2020 and beyond, uses Healthy Days to track and trend progress at the local level.

Read the study here.

Read Full Article

Humana and Astellas Scientific and Medical Affairs Inc., a U.S. subsidiary of Tokyo-based Astellas Pharma Inc., have announced a multi-year research collaboration to explore new ideas and ways to improve the health and well-being of patients and members.
Researchers and healthcare experts from both companies will study key issues and develop ways to reduce inefficiencies in the management of oncology, urology and immunology conditions.

“This research collaboration will produce knowledge in important therapeutic areas for our key population,” said William Fleming, Pharm.D., President of Humana Pharmacy Solutions. “With about 77 percent of all cancers being diagnosed in people 55 years of age and older, and 1 in 2 males and 1 in 3 females at risk for developing cancer in their lifetime, this partnership will serve to develop an important body of knowledge that will meaningfully advance the work of our respective companies.”

“We believe that the combination of Humana’s experience with affordable senior healthcare and Astellas’ commitment to advancements in healthcare, particularly in the areas of oncology, urology and transplantation will help improve the lifelong well-being of patients,” said Jeffrey Bloss, M.D., Vice President, Astellas Scientific and Medical Affairs Inc. “Through this important collaboration, we’ll use clinical data to conduct comparative effectiveness research to evaluate ways to improve healthcare and health outcomes for patients.”

Read Full Article